Literature DB >> 19324238

Obstetric emergencies.

Fadi G Mirza1, Sreedhar Gaddipati.   

Abstract

Uterine rupture, uterine inversion, and pelvic lacerations/hematomas are all associated with increased risk for hemorrhage at the time of delivery. Certain clinical factors will increase the likelihood that these complications will occur, and clinical management can be adapted to reduce risk. Prior cesarean section is a significant risk factor for uterine rupture, with the degree of risk directly related to the location and quantity of prior uterine incisions. Obstetric trauma is another independent risk factor for uterine rupture. In turn, uterine inversion has traditionally been associated with overly aggressive management of the third stage of labor. The forces of normal labor and delivery will sometimes result in lacerations and hematomas of the lower genital tract. Except for the most superficial tears, these lacerations require surgical repair to restore proper anatomical appearance and support and to limit blood loss. Trauma in pregnancy remains one of the major contributors to maternal and fetal morbidity and mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19324238     DOI: 10.1053/j.semperi.2009.01.003

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  3 in total

1.  Acute puerperal uterine inversion.

Authors:  Yoko Ihama; Maki Fukasawa; Kenji Ninomiya; Tetsuji Miyazaki
Journal:  Forensic Sci Med Pathol       Date:  2013-12-20       Impact factor: 2.007

2.  Upside-Down and Inside-Out Signs in Uterine Inversion.

Authors:  Haruka Kawano; Junichi Hasegawa; Masamitsu Nakamura; Daisuke Maruyama; Tatsuya Arakaki; Ayako Ono; Yasufumi Miyake; Akihiko Sekizawa
Journal:  J Clin Med Res       Date:  2016-05-29

3.  Predictors of uterine rupture in a large sample of women in Senegal and Mali: cross-sectional analysis of QUARITE trial data.

Authors:  Rebecca Delafield; Catherine M Pirkle; Alexandre Dumont
Journal:  BMC Pregnancy Childbirth       Date:  2018-11-01       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.